Skip to main content
. 2017 May 2;45(10):5995–6010. doi: 10.1093/nar/gkx325

Figure 3.

Figure 3.

Deficiency of topo IIα and topo IIβ impairs the decatenation checkpoint in HL-60 and MEF cells. (A) Pseudomitotic index of HL-60 cells stably transfected with shRNAs targeted to GFP (HL60/si-GFP), topo IIα (HL60/si-topo IIα) or topo IIβ (HL60/si-topo IIβ). Columns represent the mean of three biological replicates and the bars indicate standard deviations. *P < 0.05, ***P < 0.001, ****P < 0.0001 (two-sample t-test was used to compare data sets). (B) Pseudomitotic index of parental HL-60, HL-60/AMSA-R/vector or HL-60/AMSA-R/topo IIβ cells. Columns represent the mean of three biological replicates and the bars indicate standard deviations. **P < 0.01 (two-sample t-test was used to compare data sets). (C) Pseudomitotic index of MEF topo IIβ +/+ and topo IIβ -/- cells. Columns represent the mean of three biological replicates and the bars indicate standard deviations. *P < 0.05 (two-sample t-test was used to compare data sets).